A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure

<p>Proportion of ITT subjects in NIH-defined blood pressure categories at weeks 0, 2, 4, and 8 of the study based on office blood pressure. ITT: intention-to-treat; NIH: National Institutes of Health; RPC: Refined Peptide Concentrate; ∗∗∗: p=0.006, for the difference between groups in the distribution of subjects across NIH-defined blood pressure categories, favouring RPC over placebo.</p>

International Journal of Hypertension

fig2

Figure 2

Figure 2: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure 